Networth Advisors’s United Therapeutics UTHR Stock Holding History

Networth Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8	Closed	-$4.74K	–	437
2026 Q1	$4.74K	Buy	+8	New	+$3.98K	﹤0.01%	247

Other funds holding UTHR

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Networth Advisors's UTHR Position: Q2 2026 in Review

Networth Advisors sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 8 shares — an estimated $4.74K sold.

Networth Advisors first reported a position in UTHR in Q1 2026 and held it in 1 quarter. The position peaked at $4.74K in Q1 2026. 379 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Networth Advisors reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
Networth Advisors sold 8 United Therapeutics shares in Q2 2026, an estimated $4.74K.
Networth Advisors first reported a position in United Therapeutics in Q1 2026 and held it in 1 quarter.
Networth Advisors's United Therapeutics position peaked at $4.74K in Q1 2026.
379 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Networth Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.